【FWD】Support Program for Foreign HIV Patients x Receiving Medication Within 2 Years in Taiwan
To reduce healthcare barriers for foreign HIV patients in Taiwan and to enhance the effectiveness of HIV prevention and treatment, this program is jointly administered by the Taiwan CDC and Gilead Sciences. It aims to assist foreign HIV patients in Taiwan who do not qualify for government subsidies and must cover their treatment costs themselves, especially those in economically disadvantaged situations, to receive consistent HIV treatment in Taiwan. The program seeks to prevent the increased risks of severe illness and virus transmission due to lack of or interrupted treatment. The program will begin on August 1, 2024 and will continue until the donated medications are exhausted.
Please see https://www.cdc.gov.tw/Category/MPage/IobI3FJ6ir4-Ztk0m0nWPw for more details.
【轉知】衛生福利部疾病管制署有關「在臺外籍愛滋感染者 服藥2年內支持計畫」宣導資訊
衛生福利部疾病管制署為降低在臺外籍愛滋感染者(下稱外籍感染者)就醫障礙並提升我國愛滋防治成效,自2024年8月1日起開始推動支持計畫,藉以鼓勵經濟弱勢且未符合公費或健保醫療補助之在臺外籍愛滋感染者(包含:外籍學生、無收入或每月薪資低於新臺幣4萬8,000元之外籍移工或外籍人士等)接受治療,提升其服藥率及病毒量測不到比率,以維護身體健康並降低社區傳播風險。
相關檔案亦可於該署網頁(https://www.cdc.gov.tw/Category/MPage/IobI3FJ6ir4-Ztk0m0nWPw )查詢參考運用。
Any dispute over interpretation of these information shall be resolved based on the Chinese version.